Vector
Tick-Borne Relapsing Fever
search
Tick-Borne Relapsing Fever
, Relapsing Fever
See Also
Tick-Borne Illness
Borrelia
Vector Borne Disease
Prevention of Tick-borne Infection
Tick Removal
Epidemiology
Rare: <500 cases reported in U.S. in last 25 years
Region
U.S. West of the Mississippi River
More common in mountains
Pathophysiology
Cause
Spirochete
in
Borrelia
genus
Vectors
Soft Ticks (Ornithodoros genus)
Other
Borrelia
species cause Relapsing Fever in Africa and Russia
Borrelia
hermsii (reservoir: Squirrels and chipmunks)
Borrelia
tunicate (reservoir: Cattle, rodents, pigs)
Borrelia
miyamotoi
Body Lice
(human to human transmission)
Borrelia
recurrentis
Exposure
Mountain cabin with rodents
Cave exploration
Work under buidlings
Relapsing Fever
Infections often involve multiple
Borrelia
serotypes
As one serotype is cleared, another proliferates
May lie dormant in liver,
Spleen
, CNS, marrow
Alternating serotypes, dormancy cause Relapsing Fever
Symptoms (follows 7 day Incubation Period)
Fever
Sudden onset, over 102.5 F (39.2 C)
May rise over 104 F
Pattern
Fever
for 3 to 6 days
Febrile period ends with 30 minute crisis period
Brief spike in pulse and
Blood Pressure
Sweats occur as the fever abates
Fever
recurs every 4 to 14 days
Associated symptoms
Headache
Myalgias and
Arthralgia
s
Shaking Chills (rigors)
Profuse diaphoresis (as fever resolves)
Nausea
or
Vomiting
Abdominal Pain
Signs
See Complications (below)
Tachycardia
Hypertension
Hepatomegaly
(10%)
Splenomegaly
(6%)
Labs
Diagnosis
Test Sensitivity
is highest during febrile periods
Microscopic exam of blood, CSF other body fluid
Thick and thin smears stained with Wright's or Giemsa (or dark microscopy)
Spirochete
s identified
Blood Culture
s during febrile period
Immunofluorescence and PCR not widely available
Labs
Other findings
Complete Blood Count
Anemia
Slight
Leukocytosis
Thrombocytopenia
Liver Function Test
s
Increased
Unconjugated Bilirubin
Increased
Aminotransferase
s
Urinalysis
Proteinuria
and
Hematuria
Labs
If indicated
Myocarditis
suspected
EKG with
Prolonged QT
interval (QTc)
Meningitis
suspected
CSF mononuclear
Pleocytosis
and increased
CSF Protein
Management
Risk of
Jarisch-Herxheimer Reaction
with treatment (see below)
Tick-Borne Infection
Doxycycline
100 mg oral or IV twice daily for 7-10 days (preferred) OR
Erythromycin
500 mg orally qid for 7-10 days
Louse-borne Infection
Tetracycline
500 mg oral or IV once OR
Erythromycin
500 mg oral or IV once
Central Nervous System
Involvement
Ceftriaxone
IV OR
Penicillin G
IV
Complications
Jarisch-Herxheimer Reaction
(54% of treated cases)
Occurs with treatment of
Spirochete
disease (similar to
Syphilis
treatment)
Onset within 2 hours of starting treatment
Observe for 12 to 24 hours after starting treatment
Neurologic
Meningitis
(2%)
Encephalopathy
Cranial Nerve
palsy (e.g.
Bell's Palsy
,
Deafness
)
Altered Level of Consciousness
(
Delirium
, coma)
Cardiopulmonary
Acute Respiratory Distress Syndrome
(
ARDS
)
Pneumonitis
Myocarditis
Ocular
Iridiocyclitis
Iritis
Uveitis
Prognosis
Mortality <1% in treated cases
Poor prognostic factors
Myocarditis
Altered Level of Consciousness
Poor liver function
Bleeding complications from multiple sites
Prevention
See
Prevention of Tick-borne Infection
Spray susceptible buildings with
Malathion
0.5%
Keep home free of rodents
References
Dworkin (2002) Med Clin North Am 86:417-33 [PubMed]
Pace (2020) Am Fam Physician 101(9): 530-40 [PubMed]
Roscoe (2005) Am Fam Physician 72(10):2039-44 [PubMed]
Type your search phrase here